How Lateral Flow Assays Work | Early Cancer Diagnostics Guide
How Lateral Flow Assays Work: A Guide to Rapid Diagnostic Technology in Early Cancer Diagnostics How Lateral Flow Assays Work Lateral flow assays (LFAs) are among the most widely used…
Stay informed with the latest news, company updates, research highlights, industry perspectives, and strategic developments from OncoFirm™ Diagnostics. Our Newsroom shares stories about cancer diagnostic innovation, biomarker research, AI-assisted technologies, collaborations, intellectual property, and the evolving future of rapid and accessible cancer detection.
“By detecting cancer at its earliest, most treatable stage, OncoFirm empowers healthcare workers and systems to save more lives — efficiently and affordably.”
OncoFirm Scientific Publications
© 2025 OncoFirm Diagnostics Corporation. All Rights Reserved.
How Lateral Flow Assays Work: A Guide to Rapid Diagnostic Technology in Early Cancer Diagnostics How Lateral Flow Assays Work Lateral flow assays (LFAs) are among the most widely used…
Why Early Cancer Detection Matters: The Foundation of Modern Cancer Diagnostics Why Early Detection Matters Early cancer detection is one of the most significant factors influencing patient care, treatment planning,…
How AI-driven biomarkers turn test results into precision diagnostics: proven algorithm-based tests, how they are validated, FDA oversight and what comes next.
What 2025 PNAS studies on ccfDNA and the MIGHT AI method show about early cancer detection, inflammation false positives and protein biomarkers.
1. Explosive Global Growth 2. Clinical Need Meets Technological Promise 3. Regional Drivers and Adoption Summary Table Metric Value 2024 Global Market Size USD 1.0 – 1.24 billion 2030 Forecast…
How peanut agglutinin (PNA) detects the cancer-associated Thomsen–Friedenreich (TF) antigen, its research uses, its limits and the path to blood tests.
Why the Thomsen–Friedenreich (TF) antigen becomes exposed: cancer glycosylation changes, bacterial neuraminidase, inflammation, development and lab factors.
What biochemical diagnostics is, what it measures, how lab and point-of-care tests work, how results are interpreted and kept accurate, and its role in cancer.
What causes high alpha-fetoprotein (AFP)? Liver cancer and liver disease, germ cell tumors, pregnancy, rare inherited causes, lab factors and what levels mean.
How AI-driven biomarkers power multi-cancer early detection blood tests, what PATHFINDER 2 and NHS-Galleri showed, 2026 FDA status and what is unproven.